English
简体中文
Total: £ 56.28
Published Date: 2025-12-09 | Pages: 109 | Tables: 104 | Medical Care
The global market for Decentralized Clinical Trial Solution was valued at US$ 7848 million in the year 2024 and is projected to reach a revised size of US$ 15930 million by 2031, growing at a CAGR of 10.8% during the forecast period.
A Decentralized Clinical Trial (DCT) solution refers to a method of conducting clinical trials in which traditional trial activities, such as patient recruitment, data collection, and monitoring, are conducted remotely or outside of the traditional clinical trial setting. This approach leverages technology to streamline trial processes, reduce the burden on participants, and potentially improve the efficiency and accuracy of data collection.
The Decentralized Clinical Trial (DCT) Solution market has witnessed significant growth in recent years, fueled by the increasing adoption of digital technologies and the need for more efficient and patient-centric trial processes. Major sales regions for DCT solutions include North America, Europe, and Asia Pacific, driven by the presence of prominent pharmaceutical and biotechnology companies, supportive regulatory environments, and growing investments in healthcare IT infrastructure. However, despite the market's rapid expansion, there remains a degree of concentration among a few key players, leading to potential challenges for smaller vendors to penetrate the market. Nonetheless, opportunities abound, particularly in developing regions where there is a growing emphasis on healthcare digitization and expanding clinical trial capabilities. Challenges such as regulatory compliance, data security, and interoperability issues persist but are being addressed through collaborations between industry stakeholders and advancements in technology. As the healthcare landscape continues to evolve, the DCT Solution market is poised for further growth, offering innovative solutions to streamline clinical trial processes and improve patient outcomes.
This report aims to provide a comprehensive presentation of the global market for Decentralized Clinical Trial Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Decentralized Clinical Trial Solution.
The Decentralized Clinical Trial Solution market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Decentralized Clinical Trial Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, by the Driving Motives of Trial Implementation and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Decentralized Clinical Trial Solution companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ICON
Medpace
Oracle
Patheon
Medidata Solutions
IQVIA
Parexel
PPD
Science 37
Signant Health
Syneos Health
Obvio Health
Fortrea
ProPharma
Cloudbyz
Q 2 Solutions
Advarra
Medrio
Huma
THREAD
Cogstate
Veristat
Clario
HCL Technologies Limited
Segment by Type
Hybrid Clinical Trial
Completely Decentralized Clinical Trial
Segment by the Driving Motives of Trial Implementation
Necessity-driven DCT Solutions
Operational Benefit-driven DCT Solutions
Scientific Question-driven DCT Solutions
Endpoint and Platform Validation-driven DCT Solutions
Segment by the Data Collection and Transmission Methods
Wearable Device-based DCT Solutions
Mobile Application/WeChat Mini Program-based DCT Solutions
Electronic Health Record (EHR)-integrated DCT Solutions
Segment by Application
Oncology
Cardiovascular
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by the Driving Motives of Trial Implementation etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Decentralized Clinical Trial Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Decentralized Clinical Trial Solution Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hybrid Clinical Trial
1.2.3 Completely Decentralized Clinical Trial
1.3 Market by the Driving Motives of Trial Implementation
1.3.1 Global Decentralized Clinical Trial Solution Market Size Growth Rate by the Driving Motives of Trial Implementation: 2020 VS 2024 VS 2031
1.3.2 Necessity-driven DCT Solutions
1.3.3 Operational Benefit-driven DCT Solutions
1.3.4 Scientific Question-driven DCT Solutions
1.3.5 Endpoint and Platform Validation-driven DCT Solutions
1.4 Market by the Data Collection and Transmission Methods
1.4.1 Global Decentralized Clinical Trial Solution Market Size Growth Rate by the Data Collection and Transmission Methods: 2020 VS 2024 VS 2031
1.4.2 Wearable Device-based DCT Solutions
1.4.3 Mobile Application/WeChat Mini Program-based DCT Solutions
1.4.4 Electronic Health Record (EHR)-integrated DCT Solutions
1.5 Market by Application
1.5.1 Global Decentralized Clinical Trial Solution Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Oncology
1.5.3 Cardiovascular
1.5.4 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Decentralized Clinical Trial Solution Market Perspective (2020-2031)
2.2 Global Decentralized Clinical Trial Solution Growth Trends by Region
2.2.1 Global Decentralized Clinical Trial Solution Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Decentralized Clinical Trial Solution Historic Market Size by Region (2020-2025)
2.2.3 Decentralized Clinical Trial Solution Forecasted Market Size by Region (2026-2031)
2.3 Decentralized Clinical Trial Solution Market Dynamics
2.3.1 Decentralized Clinical Trial Solution Industry Trends
2.3.2 Decentralized Clinical Trial Solution Market Drivers
2.3.3 Decentralized Clinical Trial Solution Market Challenges
2.3.4 Decentralized Clinical Trial Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Decentralized Clinical Trial Solution Players by Revenue
3.1.1 Global Top Decentralized Clinical Trial Solution Players by Revenue (2020-2025)
3.1.2 Global Decentralized Clinical Trial Solution Revenue Market Share by Players (2020-2025)
3.2 Global Top Decentralized Clinical Trial Solution Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Decentralized Clinical Trial Solution Revenue
3.4 Global Decentralized Clinical Trial Solution Market Concentration Ratio
3.4.1 Global Decentralized Clinical Trial Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Decentralized Clinical Trial Solution Revenue in 2024
3.5 Global Key Players of Decentralized Clinical Trial Solution Head office and Area Served
3.6 Global Key Players of Decentralized Clinical Trial Solution, Product and Application
3.7 Global Key Players of Decentralized Clinical Trial Solution, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Decentralized Clinical Trial Solution Breakdown Data by Type
4.1 Global Decentralized Clinical Trial Solution Historic Market Size by Type (2020-2025)
4.2 Global Decentralized Clinical Trial Solution Forecasted Market Size by Type (2026-2031)
5 Decentralized Clinical Trial Solution Breakdown Data by Application
5.1 Global Decentralized Clinical Trial Solution Historic Market Size by Application (2020-2025)
5.2 Global Decentralized Clinical Trial Solution Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Decentralized Clinical Trial Solution Market Size (2020-2031)
6.2 North America Decentralized Clinical Trial Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Decentralized Clinical Trial Solution Market Size by Country (2020-2025)
6.4 North America Decentralized Clinical Trial Solution Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Decentralized Clinical Trial Solution Market Size (2020-2031)
7.2 Europe Decentralized Clinical Trial Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Decentralized Clinical Trial Solution Market Size by Country (2020-2025)
7.4 Europe Decentralized Clinical Trial Solution Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Decentralized Clinical Trial Solution Market Size (2020-2031)
8.2 Asia-Pacific Decentralized Clinical Trial Solution Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Decentralized Clinical Trial Solution Market Size by Region (2020-2025)
8.4 Asia-Pacific Decentralized Clinical Trial Solution Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Decentralized Clinical Trial Solution Market Size (2020-2031)
9.2 Latin America Decentralized Clinical Trial Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Decentralized Clinical Trial Solution Market Size by Country (2020-2025)
9.4 Latin America Decentralized Clinical Trial Solution Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Decentralized Clinical Trial Solution Market Size (2020-2031)
10.2 Middle East & Africa Decentralized Clinical Trial Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Decentralized Clinical Trial Solution Market Size by Country (2020-2025)
10.4 Middle East & Africa Decentralized Clinical Trial Solution Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ICON
11.1.1 ICON Company Details
11.1.2 ICON Business Overview
11.1.3 ICON Decentralized Clinical Trial Solution Introduction
11.1.4 ICON Revenue in Decentralized Clinical Trial Solution Business (2020-2025)
11.1.5 ICON Recent Development
11.2 Medpace
11.2.1 Medpace Company Details
11.2.2 Medpace Business Overview
11.2.3 Medpace Decentralized Clinical Trial Solution Introduction
11.2.4 Medpace Revenue in Decentralized Clinical Trial Solution Business (2020-2025)
11.2.5 Medpace Recent Development
11.3 Oracle
11.3.1 Oracle Company Details
11.3.2 Oracle Business Overview
11.3.3 Oracle Decentralized Clinical Trial Solution Introduction
11.3.4 Oracle Revenue in Decentralized Clinical Trial Solution Business (2020-2025)
11.3.5 Oracle Recent Development
11.4 Patheon
11.4.1 Patheon Company Details
11.4.2 Patheon Business Overview
11.4.3 Patheon Decentralized Clinical Trial Solution Introduction
11.4.4 Patheon Revenue in Decentralized Clinical Trial Solution Business (2020-2025)
11.4.5 Patheon Recent Development
11.5 Medidata Solutions
11.5.1 Medidata Solutions Company Details
11.5.2 Medidata Solutions Business Overview
11.5.3 Medidata Solutions Decentralized Clinical Trial Solution Introduction
11.5.4 Medidata Solutions Revenue in Decentralized Clinical Trial Solution Business (2020-2025)
11.5.5 Medidata Solutions Recent Development
11.6 IQVIA
11.6.1 IQVIA Company Details
11.6.2 IQVIA Business Overview
11.6.3 IQVIA Decentralized Clinical Trial Solution Introduction
11.6.4 IQVIA Revenue in Decentralized Clinical Trial Solution Business (2020-2025)
11.6.5 IQVIA Recent Development
11.7 Parexel
11.7.1 Parexel Company Details
11.7.2 Parexel Business Overview
11.7.3 Parexel Decentralized Clinical Trial Solution Introduction
11.7.4 Parexel Revenue in Decentralized Clinical Trial Solution Business (2020-2025)
11.7.5 Parexel Recent Development
11.8 PPD
11.8.1 PPD Company Details
11.8.2 PPD Business Overview
11.8.3 PPD Decentralized Clinical Trial Solution Introduction
11.8.4 PPD Revenue in Decentralized Clinical Trial Solution Business (2020-2025)
11.8.5 PPD Recent Development
11.9 Science 37
11.9.1 Science 37 Company Details
11.9.2 Science 37 Business Overview
11.9.3 Science 37 Decentralized Clinical Trial Solution Introduction
11.9.4 Science 37 Revenue in Decentralized Clinical Trial Solution Business (2020-2025)
11.9.5 Science 37 Recent Development
11.10 Signant Health
11.10.1 Signant Health Company Details
11.10.2 Signant Health Business Overview
11.10.3 Signant Health Decentralized Clinical Trial Solution Introduction
11.10.4 Signant Health Revenue in Decentralized Clinical Trial Solution Business (2020-2025)
11.10.5 Signant Health Recent Development
11.11 Syneos Health
11.11.1 Syneos Health Company Details
11.11.2 Syneos Health Business Overview
11.11.3 Syneos Health Decentralized Clinical Trial Solution Introduction
11.11.4 Syneos Health Revenue in Decentralized Clinical Trial Solution Business (2020-2025)
11.11.5 Syneos Health Recent Development
11.12 Obvio Health
11.12.1 Obvio Health Company Details
11.12.2 Obvio Health Business Overview
11.12.3 Obvio Health Decentralized Clinical Trial Solution Introduction
11.12.4 Obvio Health Revenue in Decentralized Clinical Trial Solution Business (2020-2025)
11.12.5 Obvio Health Recent Development
11.13 Fortrea
11.13.1 Fortrea Company Details
11.13.2 Fortrea Business Overview
11.13.3 Fortrea Decentralized Clinical Trial Solution Introduction
11.13.4 Fortrea Revenue in Decentralized Clinical Trial Solution Business (2020-2025)
11.13.5 Fortrea Recent Development
11.14 ProPharma
11.14.1 ProPharma Company Details
11.14.2 ProPharma Business Overview
11.14.3 ProPharma Decentralized Clinical Trial Solution Introduction
11.14.4 ProPharma Revenue in Decentralized Clinical Trial Solution Business (2020-2025)
11.14.5 ProPharma Recent Development
11.15 Cloudbyz
11.15.1 Cloudbyz Company Details
11.15.2 Cloudbyz Business Overview
11.15.3 Cloudbyz Decentralized Clinical Trial Solution Introduction
11.15.4 Cloudbyz Revenue in Decentralized Clinical Trial Solution Business (2020-2025)
11.15.5 Cloudbyz Recent Development
11.16 Q 2 Solutions
11.16.1 Q 2 Solutions Company Details
11.16.2 Q 2 Solutions Business Overview
11.16.3 Q 2 Solutions Decentralized Clinical Trial Solution Introduction
11.16.4 Q 2 Solutions Revenue in Decentralized Clinical Trial Solution Business (2020-2025)
11.16.5 Q 2 Solutions Recent Development
11.17 Advarra
11.17.1 Advarra Company Details
11.17.2 Advarra Business Overview
11.17.3 Advarra Decentralized Clinical Trial Solution Introduction
11.17.4 Advarra Revenue in Decentralized Clinical Trial Solution Business (2020-2025)
11.17.5 Advarra Recent Development
11.18 Medrio
11.18.1 Medrio Company Details
11.18.2 Medrio Business Overview
11.18.3 Medrio Decentralized Clinical Trial Solution Introduction
11.18.4 Medrio Revenue in Decentralized Clinical Trial Solution Business (2020-2025)
11.18.5 Medrio Recent Development
11.19 Huma
11.19.1 Huma Company Details
11.19.2 Huma Business Overview
11.19.3 Huma Decentralized Clinical Trial Solution Introduction
11.19.4 Huma Revenue in Decentralized Clinical Trial Solution Business (2020-2025)
11.19.5 Huma Recent Development
11.20 THREAD
11.20.1 THREAD Company Details
11.20.2 THREAD Business Overview
11.20.3 THREAD Decentralized Clinical Trial Solution Introduction
11.20.4 THREAD Revenue in Decentralized Clinical Trial Solution Business (2020-2025)
11.20.5 THREAD Recent Development
11.21 Cogstate
11.21.1 Cogstate Company Details
11.21.2 Cogstate Business Overview
11.21.3 Cogstate Decentralized Clinical Trial Solution Introduction
11.21.4 Cogstate Revenue in Decentralized Clinical Trial Solution Business (2020-2025)
11.21.5 Cogstate Recent Development
11.22 Veristat
11.22.1 Veristat Company Details
11.22.2 Veristat Business Overview
11.22.3 Veristat Decentralized Clinical Trial Solution Introduction
11.22.4 Veristat Revenue in Decentralized Clinical Trial Solution Business (2020-2025)
11.22.5 Veristat Recent Development
11.23 Clario
11.23.1 Clario Company Details
11.23.2 Clario Business Overview
11.23.3 Clario Decentralized Clinical Trial Solution Introduction
11.23.4 Clario Revenue in Decentralized Clinical Trial Solution Business (2020-2025)
11.23.5 Clario Recent Development
11.24 HCL Technologies Limited
11.24.1 HCL Technologies Limited Company Details
11.24.2 HCL Technologies Limited Business Overview
11.24.3 HCL Technologies Limited Decentralized Clinical Trial Solution Introduction
11.24.4 HCL Technologies Limited Revenue in Decentralized Clinical Trial Solution Business (2020-2025)
11.24.5 HCL Technologies Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Decentralized Clinical Trial Solution Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Hybrid Clinical Trial
Table 3. Key Players of Completely Decentralized Clinical Trial
Table 4. Global Decentralized Clinical Trial Solution Market Size Growth Rate by the Driving Motives of Trial Implementation (US$ Million): 2020 VS 2024 VS 2031
Table 5. Key Players of Necessity-driven DCT Solutions
Table 6. Key Players of Operational Benefit-driven DCT Solutions
Table 7. Key Players of Scientific Question-driven DCT Solutions
Table 8. Key Players of Endpoint and Platform Validation-driven DCT Solutions
Table 9. Global Decentralized Clinical Trial Solution Market Size Growth Rate by the Data Collection and Transmission Methods (US$ Million): 2020 VS 2024 VS 2031
Table 10. Key Players of Wearable Device-based DCT Solutions
Table 11. Key Players of Mobile Application/WeChat Mini Program-based DCT Solutions
Table 12. Key Players of Electronic Health Record (EHR)-integrated DCT Solutions
Table 13. Global Decentralized Clinical Trial Solution Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 14. Global Decentralized Clinical Trial Solution Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 15. Global Decentralized Clinical Trial Solution Market Size by Region (2020-2025) & (US$ Million)
Table 16. Global Decentralized Clinical Trial Solution Market Share by Region (2020-2025)
Table 17. Global Decentralized Clinical Trial Solution Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 18. Global Decentralized Clinical Trial Solution Market Share by Region (2026-2031)
Table 19. Decentralized Clinical Trial Solution Market Trends
Table 20. Decentralized Clinical Trial Solution Market Drivers
Table 21. Decentralized Clinical Trial Solution Market Challenges
Table 22. Decentralized Clinical Trial Solution Market Restraints
Table 23. Global Decentralized Clinical Trial Solution Revenue by Players (2020-2025) & (US$ Million)
Table 24. Global Decentralized Clinical Trial Solution Market Share by Players (2020-2025)
Table 25. Global Top Decentralized Clinical Trial Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Decentralized Clinical Trial Solution as of 2024)
Table 26. Ranking of Global Top Decentralized Clinical Trial Solution Companies by Revenue (US$ Million) in 2024
Table 27. Global 5 Largest Players Market Share by Decentralized Clinical Trial Solution Revenue (CR5 and HHI) & (2020-2025)
Table 28. Global Key Players of Decentralized Clinical Trial Solution, Headquarters and Area Served
Table 29. Global Key Players of Decentralized Clinical Trial Solution, Product and Application
Table 30. Global Key Players of Decentralized Clinical Trial Solution, Date of Enter into This Industry
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Decentralized Clinical Trial Solution Market Size by Type (2020-2025) & (US$ Million)
Table 33. Global Decentralized Clinical Trial Solution Revenue Market Share by Type (2020-2025)
Table 34. Global Decentralized Clinical Trial Solution Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 35. Global Decentralized Clinical Trial Solution Revenue Market Share by Type (2026-2031)
Table 36. Global Decentralized Clinical Trial Solution Market Size by Application (2020-2025) & (US$ Million)
Table 37. Global Decentralized Clinical Trial Solution Revenue Market Share by Application (2020-2025)
Table 38. Global Decentralized Clinical Trial Solution Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 39. Global Decentralized Clinical Trial Solution Revenue Market Share by Application (2026-2031)
Table 40. North America Decentralized Clinical Trial Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. North America Decentralized Clinical Trial Solution Market Size by Country (2020-2025) & (US$ Million)
Table 42. North America Decentralized Clinical Trial Solution Market Size by Country (2026-2031) & (US$ Million)
Table 43. Europe Decentralized Clinical Trial Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Europe Decentralized Clinical Trial Solution Market Size by Country (2020-2025) & (US$ Million)
Table 45. Europe Decentralized Clinical Trial Solution Market Size by Country (2026-2031) & (US$ Million)
Table 46. Asia-Pacific Decentralized Clinical Trial Solution Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 47. Asia-Pacific Decentralized Clinical Trial Solution Market Size by Region (2020-2025) & (US$ Million)
Table 48. Asia-Pacific Decentralized Clinical Trial Solution Market Size by Region (2026-2031) & (US$ Million)
Table 49. Latin America Decentralized Clinical Trial Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 50. Latin America Decentralized Clinical Trial Solution Market Size by Country (2020-2025) & (US$ Million)
Table 51. Latin America Decentralized Clinical Trial Solution Market Size by Country (2026-2031) & (US$ Million)
Table 52. Middle East & Africa Decentralized Clinical Trial Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 53. Middle East & Africa Decentralized Clinical Trial Solution Market Size by Country (2020-2025) & (US$ Million)
Table 54. Middle East & Africa Decentralized Clinical Trial Solution Market Size by Country (2026-2031) & (US$ Million)
Table 55. ICON Company Details
Table 56. ICON Business Overview
Table 57. ICON Decentralized Clinical Trial Solution Product
Table 58. ICON Revenue in Decentralized Clinical Trial Solution Business (2020-2025) & (US$ Million)
Table 59. ICON Recent Development
Table 60. Medpace Company Details
Table 61. Medpace Business Overview
Table 62. Medpace Decentralized Clinical Trial Solution Product
Table 63. Medpace Revenue in Decentralized Clinical Trial Solution Business (2020-2025) & (US$ Million)
Table 64. Medpace Recent Development
Table 65. Oracle Company Details
Table 66. Oracle Business Overview
Table 67. Oracle Decentralized Clinical Trial Solution Product
Table 68. Oracle Revenue in Decentralized Clinical Trial Solution Business (2020-2025) & (US$ Million)
Table 69. Oracle Recent Development
Table 70. Patheon Company Details
Table 71. Patheon Business Overview
Table 72. Patheon Decentralized Clinical Trial Solution Product
Table 73. Patheon Revenue in Decentralized Clinical Trial Solution Business (2020-2025) & (US$ Million)
Table 74. Patheon Recent Development
Table 75. Medidata Solutions Company Details
Table 76. Medidata Solutions Business Overview
Table 77. Medidata Solutions Decentralized Clinical Trial Solution Product
Table 78. Medidata Solutions Revenue in Decentralized Clinical Trial Solution Business (2020-2025) & (US$ Million)
Table 79. Medidata Solutions Recent Development
Table 80. IQVIA Company Details
Table 81. IQVIA Business Overview
Table 82. IQVIA Decentralized Clinical Trial Solution Product
Table 83. IQVIA Revenue in Decentralized Clinical Trial Solution Business (2020-2025) & (US$ Million)
Table 84. IQVIA Recent Development
Table 85. Parexel Company Details
Table 86. Parexel Business Overview
Table 87. Parexel Decentralized Clinical Trial Solution Product
Table 88. Parexel Revenue in Decentralized Clinical Trial Solution Business (2020-2025) & (US$ Million)
Table 89. Parexel Recent Development
Table 90. PPD Company Details
Table 91. PPD Business Overview
Table 92. PPD Decentralized Clinical Trial Solution Product
Table 93. PPD Revenue in Decentralized Clinical Trial Solution Business (2020-2025) & (US$ Million)
Table 94. PPD Recent Development
Table 95. Science 37 Company Details
Table 96. Science 37 Business Overview
Table 97. Science 37 Decentralized Clinical Trial Solution Product
Table 98. Science 37 Revenue in Decentralized Clinical Trial Solution Business (2020-2025) & (US$ Million)
Table 99. Science 37 Recent Development
Table 100. Signant Health Company Details
Table 101. Signant Health Business Overview
Table 102. Signant Health Decentralized Clinical Trial Solution Product
Table 103. Signant Health Revenue in Decentralized Clinical Trial Solution Business (2020-2025) & (US$ Million)
Table 104. Signant Health Recent Development
Table 105. Syneos Health Company Details
Table 106. Syneos Health Business Overview
Table 107. Syneos Health Decentralized Clinical Trial Solution Product
Table 108. Syneos Health Revenue in Decentralized Clinical Trial Solution Business (2020-2025) & (US$ Million)
Table 109. Syneos Health Recent Development
Table 110. Obvio Health Company Details
Table 111. Obvio Health Business Overview
Table 112. Obvio Health Decentralized Clinical Trial Solution Product
Table 113. Obvio Health Revenue in Decentralized Clinical Trial Solution Business (2020-2025) & (US$ Million)
Table 114. Obvio Health Recent Development
Table 115. Fortrea Company Details
Table 116. Fortrea Business Overview
Table 117. Fortrea Decentralized Clinical Trial Solution Product
Table 118. Fortrea Revenue in Decentralized Clinical Trial Solution Business (2020-2025) & (US$ Million)
Table 119. Fortrea Recent Development
Table 120. ProPharma Company Details
Table 121. ProPharma Business Overview
Table 122. ProPharma Decentralized Clinical Trial Solution Product
Table 123. ProPharma Revenue in Decentralized Clinical Trial Solution Business (2020-2025) & (US$ Million)
Table 124. ProPharma Recent Development
Table 125. Cloudbyz Company Details
Table 126. Cloudbyz Business Overview
Table 127. Cloudbyz Decentralized Clinical Trial Solution Product
Table 128. Cloudbyz Revenue in Decentralized Clinical Trial Solution Business (2020-2025) & (US$ Million)
Table 129. Cloudbyz Recent Development
Table 130. Q 2 Solutions Company Details
Table 131. Q 2 Solutions Business Overview
Table 132. Q 2 Solutions Decentralized Clinical Trial Solution Product
Table 133. Q 2 Solutions Revenue in Decentralized Clinical Trial Solution Business (2020-2025) & (US$ Million)
Table 134. Q 2 Solutions Recent Development
Table 135. Advarra Company Details
Table 136. Advarra Business Overview
Table 137. Advarra Decentralized Clinical Trial Solution Product
Table 138. Advarra Revenue in Decentralized Clinical Trial Solution Business (2020-2025) & (US$ Million)
Table 139. Advarra Recent Development
Table 140. Medrio Company Details
Table 141. Medrio Business Overview
Table 142. Medrio Decentralized Clinical Trial Solution Product
Table 143. Medrio Revenue in Decentralized Clinical Trial Solution Business (2020-2025) & (US$ Million)
Table 144. Medrio Recent Development
Table 145. Huma Company Details
Table 146. Huma Business Overview
Table 147. Huma Decentralized Clinical Trial Solution Product
Table 148. Huma Revenue in Decentralized Clinical Trial Solution Business (2020-2025) & (US$ Million)
Table 149. Huma Recent Development
Table 150. THREAD Company Details
Table 151. THREAD Business Overview
Table 152. THREAD Decentralized Clinical Trial Solution Product
Table 153. THREAD Revenue in Decentralized Clinical Trial Solution Business (2020-2025) & (US$ Million)
Table 154. THREAD Recent Development
Table 155. Cogstate Company Details
Table 156. Cogstate Business Overview
Table 157. Cogstate Decentralized Clinical Trial Solution Product
Table 158. Cogstate Revenue in Decentralized Clinical Trial Solution Business (2020-2025) & (US$ Million)
Table 159. Cogstate Recent Development
Table 160. Veristat Company Details
Table 161. Veristat Business Overview
Table 162. Veristat Decentralized Clinical Trial Solution Product
Table 163. Veristat Revenue in Decentralized Clinical Trial Solution Business (2020-2025) & (US$ Million)
Table 164. Veristat Recent Development
Table 165. Clario Company Details
Table 166. Clario Business Overview
Table 167. Clario Decentralized Clinical Trial Solution Product
Table 168. Clario Revenue in Decentralized Clinical Trial Solution Business (2020-2025) & (US$ Million)
Table 169. Clario Recent Development
Table 170. HCL Technologies Limited Company Details
Table 171. HCL Technologies Limited Business Overview
Table 172. HCL Technologies Limited Decentralized Clinical Trial Solution Product
Table 173. HCL Technologies Limited Revenue in Decentralized Clinical Trial Solution Business (2020-2025) & (US$ Million)
Table 174. HCL Technologies Limited Recent Development
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
Table 178. Authors List of This Report
List of Figures
Figure 1. Decentralized Clinical Trial Solution Picture
Figure 2. Global Decentralized Clinical Trial Solution Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Decentralized Clinical Trial Solution Market Share by Type: 2024 VS 2031
Figure 4. Hybrid Clinical Trial Features
Figure 5. Completely Decentralized Clinical Trial Features
Figure 6. Global Decentralized Clinical Trial Solution Market Size Comparison by the Driving Motives of Trial Implementation (2020-2031) & (US$ Million)
Figure 7. Necessity-driven DCT Solutions Features
Figure 8. Operational Benefit-driven DCT Solutions Features
Figure 9. Scientific Question-driven DCT Solutions Features
Figure 10. Endpoint and Platform Validation-driven DCT Solutions Features
Figure 11. Global Decentralized Clinical Trial Solution Market Size Comparison by the Data Collection and Transmission Methods (2020-2031) & (US$ Million)
Figure 12. Wearable Device-based DCT Solutions Features
Figure 13. Mobile Application/WeChat Mini Program-based DCT Solutions Features
Figure 14. Electronic Health Record (EHR)-integrated DCT Solutions Features
Figure 15. Global Decentralized Clinical Trial Solution Market Size by Application (2020-2031) & (US$ Million)
Figure 16. Global Decentralized Clinical Trial Solution Market Share by Application: 2024 VS 2031
Figure 17. Oncology Case Studies
Figure 18. Cardiovascular Case Studies
Figure 19. Others Case Studies
Figure 20. Decentralized Clinical Trial Solution Report Years Considered
Figure 21. Global Decentralized Clinical Trial Solution Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 22. Global Decentralized Clinical Trial Solution Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 23. Global Decentralized Clinical Trial Solution Market Share by Region: 2024 VS 2031
Figure 24. Global Decentralized Clinical Trial Solution Market Share by Players in 2024
Figure 25. Global Decentralized Clinical Trial Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. The Top 10 and 5 Players Market Share by Decentralized Clinical Trial Solution Revenue in 2024
Figure 27. North America Decentralized Clinical Trial Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. North America Decentralized Clinical Trial Solution Market Share by Country (2020-2031)
Figure 29. United States Decentralized Clinical Trial Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Canada Decentralized Clinical Trial Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Europe Decentralized Clinical Trial Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Europe Decentralized Clinical Trial Solution Market Share by Country (2020-2031)
Figure 33. Germany Decentralized Clinical Trial Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. France Decentralized Clinical Trial Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. U.K. Decentralized Clinical Trial Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Italy Decentralized Clinical Trial Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Russia Decentralized Clinical Trial Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Ireland Decentralized Clinical Trial Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Decentralized Clinical Trial Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Decentralized Clinical Trial Solution Market Share by Region (2020-2031)
Figure 41. China Decentralized Clinical Trial Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Japan Decentralized Clinical Trial Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. South Korea Decentralized Clinical Trial Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Decentralized Clinical Trial Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. India Decentralized Clinical Trial Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Australia & New Zealand Decentralized Clinical Trial Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Latin America Decentralized Clinical Trial Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Latin America Decentralized Clinical Trial Solution Market Share by Country (2020-2031)
Figure 49. Mexico Decentralized Clinical Trial Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Brazil Decentralized Clinical Trial Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Middle East & Africa Decentralized Clinical Trial Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Middle East & Africa Decentralized Clinical Trial Solution Market Share by Country (2020-2031)
Figure 53. Israel Decentralized Clinical Trial Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Decentralized Clinical Trial Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. UAE Decentralized Clinical Trial Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. ICON Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2020-2025)
Figure 57. Medpace Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2020-2025)
Figure 58. Oracle Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2020-2025)
Figure 59. Patheon Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2020-2025)
Figure 60. Medidata Solutions Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2020-2025)
Figure 61. IQVIA Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2020-2025)
Figure 62. Parexel Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2020-2025)
Figure 63. PPD Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2020-2025)
Figure 64. Science 37 Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2020-2025)
Figure 65. Signant Health Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2020-2025)
Figure 66. Syneos Health Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2020-2025)
Figure 67. Obvio Health Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2020-2025)
Figure 68. Fortrea Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2020-2025)
Figure 69. ProPharma Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2020-2025)
Figure 70. Cloudbyz Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2020-2025)
Figure 71. Q 2 Solutions Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2020-2025)
Figure 72. Advarra Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2020-2025)
Figure 73. Medrio Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2020-2025)
Figure 74. Huma Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2020-2025)
Figure 75. THREAD Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2020-2025)
Figure 76. Cogstate Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2020-2025)
Figure 77. Veristat Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2020-2025)
Figure 78. Clario Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2020-2025)
Figure 79. HCL Technologies Limited Revenue Growth Rate in Decentralized Clinical Trial Solution Business (2020-2025)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
